DENALI THERAPEUTICS INC filings

SEC filings by DENALI THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-13BRATTON DOUGLAS KDenali Therapeutics Inc.5,750,8824.2%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCDenali Therapeutics Inc.10,834,4837.8%EDGAR
SC 13G/A2024-02-12BIOGEN INC.Denali Therapeutics Inc.12,751,365-EDGAR
SC 13G2024-02-08WELLINGTON MANAGEMENT GROUP LLPDenali Therapeutics Inc.7,274,7175.3%EDGAR
SC 13G/A2024-01-30BAILLIE GIFFORD & CODenali Therapeutics Inc.14,260,72410.3%EDGAR
SC 13G/A2024-01-30Temasek Holdings (Private) LtdDenali Therapeutics Inc.6,895,9924.9%EDGAR
SC 13G/A2024-01-25BlackRock Inc.Denali Therapeutics Inc.11,542,8618.4%EDGAR
SC 13G2023-03-30Temasek Holdings (Private) LtdDenali Therapeutics Inc.6,895,9925.0%EDGAR
SC 13G/A2023-02-13BRATTON DOUGLAS KDenali Therapeutics Inc.7,000,8825.2%EDGAR
SC 13G/A2023-02-09FMR LLCDenali Therapeutics Inc.5,854,0354.3%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCDenali Therapeutics Inc.9,947,0987.3%EDGAR
SC 13G/A2023-02-01BlackRock Inc.Denali Therapeutics Inc.9,321,4296.9%EDGAR
SC 13G/A2023-01-20BAILLIE GIFFORD & CODenali Therapeutics Inc.15,119,47411.1%EDGAR
SC 13G/A2022-02-14PRICE T ROWE ASSOCIATES INC /MD/Denali Therapeutics Inc.4,635,4333.7%EDGAR
SC 13G/A2022-02-14BRATTON DOUGLAS KDenali Therapeutics Inc.7,845,1896.4%EDGAR
SC 13G/A2022-02-09FMR LLCDenali Therapeutics Inc.6,592,0335.4%EDGAR
SC 13G/A2022-02-09VANGUARD GROUP INCDenali Therapeutics Inc.8,161,5306.7%EDGAR
SC 13G/A2022-02-08ARCH Venture Fund VIII, L.P.Denali Therapeutics Inc.--EDGAR
SC 13G/A2022-02-03BlackRock Inc.Denali Therapeutics Inc.8,110,8226.6%EDGAR
SC 13G/A2022-01-18BAILLIE GIFFORD & CODenali Therapeutics Inc.15,056,38112.3%EDGAR